CVE:NSCI Nanalysis Scientific (NSCI) Stock Price, News & Analysis → Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (From The Oxford Club) (Ad) Free NSCI Stock Alerts C$0.41 -0.05 (-10.87%) (As of 05:23 PM ET) Add Compare Share Share Today's RangeC$0.41▼C$0.4650-Day RangeC$0.36▼C$0.4952-Week RangeC$0.35▼C$0.66Volume66,479 shsAverage Volume59,221 shsMarket CapitalizationC$46.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades Get Nanalysis Scientific alerts: Email Address Ad The Oxford ClubDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...Click here now to claim your FREE copy of Marc's AI playbook. About Nanalysis Scientific Stock (CVE:NSCI)Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.Read More NSCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NSCI Stock News HeadlinesMay 29, 2024 | finance.yahoo.comNanalysis Announces First Quarter 2024 ResultsMay 29, 2024 | investing.comNanalysis Scientific Corp (NSCI)May 23, 2024 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp up on Tuesday (NSCI)May 21, 2024 | finance.yahoo.comNanalysis Announces First Quarter 2024 Conference CallMay 2, 2024 | finance.yahoo.comNanalysis Scientific Full Year 2023 Earnings: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022)April 30, 2024 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp up on Monday (NSCI)April 29, 2024 | ca.finance.yahoo.comNanalysis Announces Fourth Quarter and Full Year 2023 ResultsApril 27, 2024 | msn.comStudy supports gene-directed management of BRCA1 and BRCA2 gene carriers in SingaporeApril 27, 2024 | msn.comAnalysis identifies 50 new genomic regions associated with kidney cancer riskApril 11, 2024 | ca.finance.yahoo.comNanalysis Announces Full Year 2023 Conference CallApril 10, 2024 | ca.finance.yahoo.comNanalysis Scientific Corp. Announces Director ResignationApril 4, 2024 | theglobeandmail.comAI Revolutionizes Drug Detection with Compact NMR and Machine LearningMarch 31, 2024 | msn.comScientists identify distinct molecular signatures for sepsis diagnosis and prognosisMarch 6, 2024 | ca.finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - NSCIMarch 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - NSCIFebruary 6, 2024 | finanznachrichten.deNanalysis Scientific Corp.: Nanalysis Achieves Record Revenue in Q4February 6, 2024 | msn.comNanalysis Scientific says Q4 revenue expected to be at least $9.3MFebruary 6, 2024 | finance.yahoo.comNanalysis Achieves Record Revenue in Q4January 30, 2024 | finance.yahoo.comNanalysis Scientific Corp. Provides Update on Security Services BusinessDecember 15, 2023 | theglobeandmail.comClosing Bell: Nanalysis Scientific Corp flat on Thursday (NSCI)December 2, 2023 | morningstar.comNanalysis Scientific Corp Ordinary Shares NSCIDecember 1, 2023 | finanznachrichten.deNanalysis Scientific Corp.: Nanalysis Reports Third Quarter 2023 ResultsNovember 29, 2023 | finance.yahoo.comNanalysis Reports Third Quarter 2023 ResultsNovember 15, 2023 | finance.yahoo.comNanalysis Announces Third Quarter 2023 Conference CallNovember 2, 2023 | finance.yahoo.comNanalysis Scientific Corp. (NSCIF)See More Headlines Receive NSCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolCVE:NSCI CUSIPN/A CIKN/A Webwww.nanalysis.com Phone403-769-9499FaxN/AEmployees249Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.16) Trailing P/E RatioN/A Forward P/E Ratio19.81 P/E GrowthN/ANet IncomeC$-16,200,000.00 Net Margins-56.90% Pretax MarginN/A Return on Equity-47.24% Return on Assets-13.67% Debt Debt-to-Equity Ratio93.56 Current Ratio1.23 Quick Ratio1.11 Sales & Book Value Annual SalesC$28.47 million Price / Sales1.62 Cash FlowC$0.05 per share Price / Cash Flow8.93 Book ValueC$0.23 per share Price / Book1.78Miscellaneous Outstanding Shares112,540,000Free FloatN/AMarket CapC$46.14 million OptionableNot Optionable Beta0.76 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Sean Krakiwsky M.Sc. (Age 54)Founder, CEO, President & Director Comp: $276.41kMr. Randall McRae C.A.CPA, Corporate Controller & CFOMr. Julien MullerChief Technology OfficerDr. Heather PhillipsVice President of OperationsMr. Matthew SelingerInvestor Relations ManagerDr. Susanne RiegelVice President of Marketing & Product ManagerMr. Nick MacKenzieVice President of SalesDr. Greg McFeetorsHead of ManufacturingMr. Sime BuricExecutive Vice President of ServicesRobert BorkowskyExecutive OfficerMore ExecutivesKey CompetitorsexactEarthTSE:XCTBSM TechnologiesTSE:GPSENTRECTSE:ENTEurocontrol Technics GroupCVE:EUOJEMTECCVE:JTCView All CompetitorsInsidersGuido CloetensSold 10,000 sharesTotal: C$4,700.00 ($0.47/share)Guido CloetensSold 10,000 sharesTotal: C$4,400.00 ($0.44/share)Michal OkoniewskiBought 80,000 shares on 3/18/2024Total: C$30,400.00 ($0.38/share)View All Insider Transactions NSCI Stock Analysis - Frequently Asked Questions How have NSCI shares performed in 2024? Nanalysis Scientific's stock was trading at C$0.38 at the beginning of 2024. Since then, NSCI stock has increased by 9.3% and is now trading at C$0.41. View the best growth stocks for 2024 here. What other stocks do shareholders of Nanalysis Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nanalysis Scientific investors own include Brookfield Infrastructure Partners (BIP.UN), Big 5 Sporting Goods (BGFV), BlackBerry (BB), Ayro (AYRO), Digital Turbine (APPS), Alamos Gold (AGI) and Air Canada (AC). How do I buy shares of Nanalysis Scientific? Shares of NSCI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NSCI) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. ...The Freeport Society | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanalysis Scientific Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanalysis Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.